Calf Welfare: Bovine Respiratory Disease Prevention and Treatment

Bovine respiratory disease (BRD) is the most economically significant disease in beef and dairy calves, and also a major welfare concern. It affects up to 25% of beef calves in feedlot systems and causes significant pain and distress before and during treatment.

Key Facts

BRD causes an estimated 70-80% of all calf illness in feedlot systems in the USA and UK
The disease complex involves multiple viral and bacterial pathogens acting synergistically
Calves experiencing social mixing, transport, and weaning stress have compromised immune function
Early detection and treatment within 24 hours of clinical signs improves treatment success from 50% to over 90%
Chronic BRD causes permanent lung damage affecting lifetime productivity and welfare

Welfare Considerations

BRD causes significant pain: calves with active pneumonia show elevated respiratory rate, nasal discharge, depression, reduced feed intake, and measurably elevated pain biomarkers. Traditional reliance on single-antibiotic treatment without concurrent anti-inflammatory analgesia prolongs suffering. Research shows that adding meloxicam to antibiotic treatment reduces fever duration and improves appetite recovery. Prevention through metaphylaxis, vaccination programs, and reducing mixing-transport stress is both economically and welfare-justified. Health monitoring technologies including automated cough detection and temperature-sensing ear tags enable earlier detection.

What You Can Do

Advocate for anti-inflammatory medication to be included in all BRD treatment protocols
Support research into early-detection technologies for automated BRD monitoring
Encourage farmers to minimise calf mixing events and transport duration during high-risk periods
Choose beef from farms with documented health monitoring and treatment protocols
Support veterinary antimicrobial stewardship programs that include pain management requirements